|
Japanese spotted fever
|
DOID_0050050 |
|
|
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor
|
CHEBI_63510 |
|
|
EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor
|
CHEBI_137626 |
|
|
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
|
CHEBI_49200 |
|
|
anti-ulcer drug
|
CHEBI_49201 |
|
|
Far Eastern spotted fever
|
DOID_0050046 |
|
|
CETP inhibitor
|
CHEBI_49205 |
|
|
EC 3.5.2.* (non-peptide cyclic amide C-N hydrolase) inhibitor
|
CHEBI_76808 |
|
|
EC 2.4.2.14 (amidophosphoribosyltransferase) inhibitor
|
CHEBI_138952 |
|
|
EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor
|
CHEBI_138953 |
|
|
EC 6.3.5.4 [asparagine synthase (glutamine-hydrolysing)] inhibitor
|
CHEBI_138956 |
|
|
intracranial hypotension
|
DOID_4723 |
|
|
brain edema
|
DOID_4724 |
|
|
granulosa cell tumor
|
DOID_2999 |
|
|
pineoblastoma
|
DOID_1664 |
|
|
wound botulism
|
DOID_0050353 |
|
|
EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor
|
CHEBI_84799 |
|
|
foodborne botulism
|
DOID_0050352 |
|
|
infant botulism
|
DOID_0050354 |
|
|
Sertoli-Leydig cell tumor
|
DOID_2997 |
|
